Skip to content

AARD AARD Net Change in Cash

Net Change in Cash at other companies

AbbVie logo
AbbVieABBV
$4.16B+1,293%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$6.28M+332%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$7.92M-53.3%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-$10.44M-261%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$47.71M-524%
Arvinas logo
ArvinasARVN
-$55.6M-185%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's net change in cash?
AARD (AARD) reported net change in cash of $15.39M in Q1 2026.
How has AARD's net change in cash changed year-over-year?
AARD's net change in cash increased by 143.8% year-over-year, from -$35.14M to $15.39M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.